X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (51) 51
female (36) 36
male (35) 35
adult (33) 33
middle aged (33) 33
index medicus (32) 32
aged (24) 24
hematology (24) 24
prognosis (22) 22
leukemia, lymphocytic, chronic, b-cell - genetics (18) 18
cd38 expression (17) 17
oncology (16) 16
cll (15) 15
survival (13) 13
zap-70 expression (13) 13
aged, 80 and over (12) 12
flow cytometry (12) 12
mutation (12) 12
leukemia, lymphocytic, chronic, b-cell - mortality (11) 11
leukemia, lymphocytic, chronic, b-cell - diagnosis (10) 10
gene mutation status (9) 9
leukemia, lymphocytic, chronic, b-cell - pathology (9) 9
abridged index medicus (8) 8
kaplan-meier estimate (8) 8
leukemia, lymphocytic, chronic, b-cell - metabolism (8) 8
risk factors (8) 8
chronic lymphocytic leukemia (7) 7
diagnosis (7) 7
disease-free survival (7) 7
genomic aberrations (7) 7
proportional hazards models (7) 7
receptor, notch1 - genetics (7) 7
survival rate (7) 7
antigen-driven selection (6) 6
disease progression (6) 6
follow-up studies (6) 6
immunophenotyping (6) 6
leukemia, lymphocytic, chronic, b-cell - drug therapy (6) 6
pathology (6) 6
adolescent (5) 5
b-cll (5) 5
chronic lymphocytic leukaemia (5) 5
clinical-significance (5) 5
cohort studies (5) 5
cytotoxicity, immunologic (5) 5
flow cytometry - methods (5) 5
health aspects (5) 5
hemic and lymphatic diseases (5) 5
immunoglobulin heavy chains - genetics (5) 5
immunoglobulin variable region - genetics (5) 5
leukemia, lymphocytic, chronic, b-cell - immunology (5) 5
medicine (5) 5
multivariate analysis (5) 5
phenotype (5) 5
progressive disease (5) 5
protein expression (5) 5
reference values (5) 5
reproducibility of results (5) 5
b-cell lymphoma (4) 4
biomarkers, tumor - genetics (4) 4
care and treatment (4) 4
cd49d (4) 4
cells (4) 4
flow-cytometry (4) 4
gene expression (4) 4
genetic aspects (4) 4
killer cells, natural - immunology (4) 4
leukemia, lymphocytic, chronic, b-cell - therapy (4) 4
lymphoma (4) 4
medicine, research & experimental (4) 4
neoplasm staging (4) 4
notch1 mutations (4) 4
online only (4) 4
prospective studies (4) 4
research (4) 4
retrospective studies (4) 4
rituximab (4) 4
somatic hypermutation (4) 4
time factors (4) 4
v-h genes (4) 4
variable-region mutations (4) 4
young adult (4) 4
zap-70 (4) 4
alpha-4-beta-1 integrin (3) 3
analysis (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
article (3) 3
b-cell receptor (3) 3
b-cells (3) 3
cancer (3) 3
cell biology (3) 3
cell line (3) 3
chemotherapy (3) 3
chromosome deletion (3) 3
chronic lymphatic leukemia (3) 3
disease (3) 3
fludarabine (3) 3
gene expression profiling (3) 3
genes, immunoglobulin heavy chain (3) 3
hepatitis c virus (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 10/2012, Volume 120, Issue 16, pp. 3222 - 3228
Journal Article
Journal Article
Blood, ISSN 0006-4971, 02/2013, Volume 121, Issue 8, pp. 1403 - 1412
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 02/2018, Volume 215, Issue 2, pp. 681 - 697
The Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, which antagonizes B cell receptor (BCR) signals, demonstrates remarkable clinical activity in chronic... 
SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | CLL | ACTIVATION | INTERNATIONAL WORKSHOP | THERAPY | B-CELL-RECEPTOR | INHIBITOR IBRUTINIB | IN-VIVO | BTK | VLA-4-DEPENDENT ADHESION | IMMUNOLOGY | Lymphocytosis - metabolism | Multivariate Analysis | Pyrazoles - therapeutic use | Integrin alpha4beta1 - metabolism | Lymph Nodes - pathology | Humans | Kaplan-Meier Estimate | Proportional Hazards Models | Lymph Nodes - metabolism | Lymphocytosis - pathology | Phosphatidylinositol 3-Kinases - metabolism | Pyrimidines - pharmacology | Receptors, Antigen, B-Cell - metabolism | Cell Adhesion - drug effects | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Agammaglobulinaemia Tyrosine Kinase - antagonists & inhibitors | Immunoglobulin M - metabolism | Agammaglobulinaemia Tyrosine Kinase - metabolism | Pyrimidines - therapeutic use | Progression-Free Survival | Lymph Nodes - drug effects | Protein Kinase Inhibitors - pharmacology | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Pyrazoles - pharmacology | Tyrosine | Cues | Lymphocyte receptors | Chronic lymphatic leukemia | CD49d antigen | Cell survival | Tumor cells | Leukemia | Lymphatic leukemia | CD29 antigen | B-cell receptor | VLA-4 antigen | Bruton's tyrosine kinase | Patients | Cell adhesion & migration | 1-Phosphatidylinositol 3-kinase | Cell activation | Lymphocytes B | Cell adhesion | Lymphocytosis | Protein-tyrosine kinase | 304
Journal Article
BLOOD, ISSN 0006-4971, 10/2015, Volume 126, Issue 16, pp. 1921 - 1924
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 01/2012, Volume 10, Issue 1, pp. 18 - 18
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 9, pp. 897 - 904
Journal Article
Current Cancer Drug Targets, ISSN 1568-0096, 10/2016, Volume 16, Issue 8, pp. 659 - 668
Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease characterized by the accumulation/expansion of a clonal population of neoplastic cells... 
CD49d | Therapy | CLL | Integrin | Prognosis | Microenvironment | B-CELL RECEPTOR | ALPHA-4-BETA-1 INTEGRIN | PROGRESSIVE DISEASE | therapy | TYROSINE KINASE | PREVENTS APOPTOSIS | BONE-MARROW | IN-SITU HYBRIDIZATION | prognosis | microenvironment | ADHESION MOLECULE-1 | DEPENDENT REGULATION | ONCOLOGY | integrin | GENE MUTATION STATUS
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 10/2014, Volume 93, Issue 10, pp. 1765 - 1774
Journal Article
Blood, ISSN 0006-4971, 06/2013, Volume 121, Issue 24, pp. 4902 - 4905
Journal Article